Media Coverage and Events
Excelsior Bio-System Incorporation’s Professional Performance and Brand Visibility
Excelsior Bio-System
Excelsior Bio-System Incorporation has long been dedicated to allergen testing and in vitro diagnostic technologies, continuously investing in R&D, manufacturing, and applications, while actively participating in medical industry events, international exchanges, and professional validations.
Through media coverage, professional events, and cross-regional exchanges, Excelsior Bio-System Incorporation continues to build connections with clinical stakeholders, industry partners, and international exchange platforms in areas such as diagnostic technology, quality management, and application promotion, gradually accumulating brand visibility and a foundation for collaboration.
For more media reports, event records, seminar information, and announcements, please visit the “Latest News” page for full updates.
View Latest News & Event Announcements
International Exchange and Media Coverage
As technological development and external collaborations continue to advance, Excelsior Bio-System Incorporation has also participated in media interviews and international exchange activities, allowing more external organizations to better understand the company’s focus in allergen testing and in vitro diagnostic technologies.
These reports and exchanges not only demonstrate the company’s technological application achievements, but also enable Excelsior Bio-System Incorporation to establish initial connections with partners in different regions, expanding opportunities for cross-market communication and collaboration.
View Related Media CoverageQuality Management and Professional Validation
In the field of in vitro diagnostics, quality management and testing consistency are essential foundations for building long-term trust. Excelsior Bio-System Incorporation continuously improves its products, processes, and quality management through standardized systems and external validation mechanisms.
In addition to the quality system itself, external audits and proficiency testing records also reflect the company’s strong commitment to diagnostic stability and quality control. Through continuous review and validation, Excelsior Bio-System Incorporation strengthens its quality management foundation and supports consistency across testing processes and results.
Industry Participation and Clinical Application Exchange
In addition to media coverage and quality validation, Excelsior Bio-System Incorporation continues to participate in professional medical and health-related events. Through on-site exchanges, case sharing, and application discussions, the company strengthens the connection between diagnostic technologies and real-world needs.
Through interactions with clinical stakeholders, partners, and industry organizations, Excelsior Bio-System Incorporation continuously gains insight into application requirements across different settings. This also creates more opportunities for allergen testing and health management technologies to be seen, understood, and discussed.
Key Achievements and Development Records
Over the course of its long-term development, Excelsior Bio-System Incorporation has accumulated multiple representative achievements spanning international certifications, animal disease diagnostics, pandemic applications, industry–academia collaboration, and overseas expansion.
These achievements result from continuous investment across different periods and reflect the company’s accumulated capabilities in diagnostic technologies, application development, and external collaboration.
International Certifications and Animal Disease Diagnostics
Excelsior Bio-System Incorporation continues to invest in livestock disease diagnostic technologies and has accumulated related international certifications and application achievements, demonstrating the company’s technical capability and global development potential in animal disease diagnostics.
Learn About Livestock Disease Diagnostics →Pandemic Applications and Diagnostic Technology Development
During periods of rapidly changing public health needs, Excelsior Bio-System Incorporation leveraged its existing diagnostic platforms and R&D experience to engage in the development and supply of related testing technologies, accumulating experience in pandemic applications and in vitro diagnostic product development.
View Quality Certifications & Awards →Industry–Academia Collaboration and Overseas Expansion
Excelsior Bio-System Incorporation also advances technological application and market connectivity through industry–academia collaboration and overseas market expansion, extending its existing diagnostic capabilities to a wider range of application scenarios.
Brand Extension and Application Expansion
In addition to diagnostic technologies themselves, Excelsior Bio-System Incorporation continues to extend its related health applications, including pet diagnostics, pet health products, and health-related education initiatives, gradually expanding the brand’s reach across different user groups and usage scenarios.
Through product launches, overseas expansion, health seminars, and thematic events, Excelsior Bio-System Incorporation enables diagnostics, wellness, and health management topics to go beyond the technical domain, allowing them to be better understood and accessed by a broader audience.
Learn About Our Brand Philosophy & Mission
Continuously Seen, Continuously Advancing
Excelsior Bio-System Incorporation will continue to accumulate professional foundations and brand trust in the fields of in vitro diagnostics and allergen testing through media coverage, professional events, and external exchanges.
Looking ahead, based on its existing strengths in technology, quality, and applications, Excelsior Bio-System Incorporation will continue to deepen its diagnostic technologies and health management applications, while maintaining long-term and stable collaborations with clinical stakeholders, industry partners, and international collaborators.
